The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

The Thai Innovation List was established in 2015 to compile products and services developed through Thailand’s scientific and technological knowledge and research capacity. The initiative was designed to support and promote the utilization of Thai innovations for economic development and commercialization. Medical innovations account for approxim

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

This study marks Thailand’s first application of Distributional Cost-Effectiveness Analysis (DCEA), demonstrating that the concept of “equity” can be incorporated into economic evaluation. The analysis examines dialysis options, namely peritoneal dialysis (PD) and hemodialysis (HD), for patients

Highlights • Storage tanks and wastewater treatment systems were identified as the primary sources of benzene and 1,3-butadiene emissions. • AERMOD modeling showed VOC hotspots near industries, exposing nearby communities despite overall regulatory compliance. • Traffic emissions alone exceeded

The development of medical innovation is a key strategic priority of Thailand under the 13th National Economic and Social Development Plan, which aims to position the country as a hub for high-value medical and healthcare services. However, despite the continuous growth of medical research in Thailand, many innovations have not successfully progres

BANGKOK, April 3, 2026 – At the Best Western Chatuchak Hotel, the Environmental Economics Unit (E2U) of the Health Intervention and Technology Assessment Program Foundation (HITAP), alongside national energy and environmental partners, hosted a milestone seminar: “Comprehensive Assessment of Co-bene

Thailand’s health system is facing challenges from resource constraints including limited budgets, shortages of health professionals, and restricted access to essential medical equipment. At the same time, the system continues to provide low-value care (LVC), which not only fails to deliver meaningf

Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H

Thunyarat Anothaisintawee has been graduated from Chulalongkorn University and was an internist at Lampoon Hospital. She has received certificate of Family Medicine from Pramongkutkloa Hospital. After that she has been worked as a faculty staff at Family Medicine Department, Ramathibodi Hospital, Mahidol University. Now, she is studying PhD program